BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 29357870)

  • 21. Kinetics of glucose-6-phosphate dehydrogenase (G6PD) activity during Plasmodium vivax infection: implications for early radical malaria treatment.
    Dahuron L; Goungounga J; Drame M; Douine M; Nacher M; Blaise T; Mosnier E; Musset L; Fouillet M; Djossou F; Epelboin L
    Malar J; 2024 May; 23(1):140. PubMed ID: 38725027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of G6PD deficiency and submicroscopic malaria parasites carriage in malaria hotspot area in Northwest, Tanzania.
    Manjurano A; Lyimo E; Kishamawe C; Omolo J; Mosha J; Donald M; Kazyoba P; Kapiga S; Changalucha J
    Malar J; 2023 Dec; 22(1):372. PubMed ID: 38062464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four Times of Relapse of Plasmodium vivax Malaria Despite Primaquine Treatment in a Patient with Impaired Cytochrome P450 2D6 Function.
    Choi S; Choi H; Park SY; Kwak YG; Song JE; Shin SY; Baek JH; Shin HI; Oh HS; Kim YC; Yeom JS; Han JH; Kim MJ
    Korean J Parasitol; 2022 Feb; 60(1):39-43. PubMed ID: 35247953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria.
    Baird K
    Pathog Glob Health; 2015 May; 109(3):93-106. PubMed ID: 25943156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
    Watson J; Taylor WRJ; Bancone G; Chu CS; Jittamala P; White NJ
    PLoS Negl Trop Dis; 2018 Apr; 12(4):e0006440. PubMed ID: 29677199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
    Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
    Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical and public health problem of relapse despite primaquine therapy: case review of repeated relapses of Plasmodium vivax acquired in Papua New Guinea.
    Ingram RJ; Crenna-Darusallam C; Soebianto S; Noviyanti R; Baird JK
    Malar J; 2014 Dec; 13():488. PubMed ID: 25495607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of relapsing Plasmodium vivax malaria.
    Chu CS; White NJ
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):885-900. PubMed ID: 27530139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia.
    Lo E; Zhong D; Raya B; Pestana K; Koepfli C; Lee MC; Yewhalaw D; Yan G
    Malar J; 2019 Oct; 18(1):340. PubMed ID: 31590661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementation of G6PD testing and primaquine for
    Kitchakarn S; Lek D; Thol S; Hok C; Saejeng A; Huy R; Chinanonwait N; Thimasarn K; Wongsrichanalai C
    WHO South East Asia J Public Health; 2017 Sep; 6(2):60-68. PubMed ID: 28857064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic Variation of
    Stewart AGA; Zimmerman PA; McCarthy JS
    Front Pharmacol; 2021; 12():784909. PubMed ID: 34899347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of G6PD Viangchan variant in malaria endemic areas in Lao PDR: an implication for malaria elimination by 2030.
    Ong KIC; Iwagami M; Araki H; Khattignavong P; Soundala P; Keomalaphet S; Prasayasith P; Lorpachan L; Xangsayalath P; Pongvongsa T; Hongvanthong B; Brey PT; Kano S; Jimba M
    Malar J; 2019 Mar; 18(1):75. PubMed ID: 30866940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spatial distribution of G6PD deficiency variants across malaria-endemic regions.
    Howes RE; Dewi M; Piel FB; Monteiro WM; Battle KE; Messina JP; Sakuntabhai A; Satyagraha AW; Williams TN; Baird JK; Hay SI
    Malar J; 2013 Nov; 12():418. PubMed ID: 24228846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
    Kondrashin A; Baranova AM; Ashley EA; Recht J; White NJ; Sergiev VP
    Malar J; 2014 Feb; 13():51. PubMed ID: 24502194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
    Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea.
    Goo YK; Ji SY; Shin HI; Moon JH; Cho SH; Lee WJ; Kim JY
    PLoS One; 2014; 9(5):e97390. PubMed ID: 24853873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between CYP2D6 phenotype and recurrence of Plasmodium vivax infection in south Korean patients.
    Choi S; Choi H; Park SY; Kwak YG; Song JE; Shin SY; Baek JH; Shin HI; Cho SH; Lee SE; Kwon JR; Park S; Kim M; Oh HS; Kim YC; Kim MJ; Yeom JS
    Malar J; 2022 Oct; 21(1):289. PubMed ID: 36217154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in Human Cytochrome P-450 Drug-Metabolism Genes: A Gateway to the Understanding of Plasmodium vivax Relapses.
    Silvino AC; Costa GL; Araújo FC; Ascher DB; Pires DE; Fontes CJ; Carvalho LH; Brito CF; Sousa TN
    PLoS One; 2016; 11(7):e0160172. PubMed ID: 27467145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine.
    Daher A; Aljayyoussi G; Pereira D; Lacerda MVG; Alexandre MAA; Nascimento CT; Alves JC; da Fonseca LB; da Silva DMD; Pinto DP; Rodrigues DF; Silvino ACR; de Sousa TN; de Brito CFA; Ter Kuile FO; Lalloo DG
    Malar J; 2019 Sep; 18(1):325. PubMed ID: 31547827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Case report: recurrence of Plasmodium vivax malaria due to defective cytochrome P450 2D6 function in Pos Lenjang, Pahang, Malaysia.
    Mat Salleh NH; Rahman MFA; Samsusah S; De Silva JR; Ng DC; Ghozali AH; Tan JH; Lai MY; Amir A; Liew JWK; Lau YL
    Trans R Soc Trop Med Hyg; 2020 Sep; 114(9):700-703. PubMed ID: 32511702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.